Atlas FDA

INFUSE Bone Graft

FDA premarket approval P000054/S056 · decided 2019-11-01

Approval details

PMA number
P000054
Supplement
S056
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INFUSE Bone Graft
Generic name
Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction
Applicant
Medtronic Sofamor Danek USA, Inc.
Date received
2019-09-25
Decision date
2019-11-01
Days to decision
37 days
Decision code
OK30
Product code
MPW
Advisory committee
Orthopedic
Expedited review
No
Location
Memphis, TN
Statement
Implementation of new instruments to assess percent solids in a collagen dispersion used in the manufacturing of INFUSE Bone Graft.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Catalyft PL Expandable Interbody System (K253011)Medtronic Sofamor Danek USA, Inc.2026-07-17
Symmetrix™ L Spinal System (K261020)Medtronic Sofamor Danek USA, Inc.2026-07-14
OsteoCool™ RF Ablation System; OsteoCool™ 2.0 RF Ablation System (K253656)Medtronic Sofamor Danek USA, Inc.2026-06-05
CD Horizon™ ModuLeX™ Fenestrated Screw Set; CD Horizon™ ModuLeX™ Spinal System (K260216)Medtronic Sofamor Danek USA, Inc.2026-04-21
Infinity™ OCT System (K254165)Medtronic Sofamor Danek USA, Inc.2026-01-21
CD Horizon™ ModuLeX™ Spinal System (LigaMAS Head Assembly) (K253941)Medtronic Sofamor Danek USA, Inc.2026-01-07
Infinity™ OCT System (K253129)Medtronic Sofamor Danek USA, Inc.2025-10-24
CD Horizon™ Spinal System (K253335)Medtronic Sofamor Danek USA, Inc.2025-10-24